Mode
Text Size
Log in / Sign up
N/A Completed N=177 Randomized Triple-blind Supportive Care

Auriculotherapy - Pain Management of Aspiration Abortion

Abortion in First Trimester
Source: ClinicalTrials.gov NCT03896022 ↗
Enrolled (actual)
177
Serious AEs
0.0%
Results posted
Jan 2021
Primary outcomePrimary: Pain Visual Analog Scale Score (Beads vs Placebo) — 50; 47.5 score on a scale

Summary

Primary Objective: To assess whether usual care plus auricular acupressure with beads reduces subject-reported maximum pain during first trimester vacuum aspiration compared to usual care plus placebo. Secondary Objective: To assess whether usual care plus auricular acupuncture with Pyonex™ needles reduces subject-reported maximum pain during first trimester vacuum aspiration as compared to usual care plus placebo. This assessment will replicate the previous trial and strengthen the evidence that auricular acupuncture is beneficial for aspiration abortion pain Exploratory Objective: To assess whether usual care plus either auricular acupressure with beads or auricular acupuncture with Pyonex™ needles reduces subject-reported anxiety scores during first trimester vacuum aspiration as compared to women receiving usual care plus placebo.

Outcome Measures

OutcomeResultp-value
PRIMARY
Pain Visual Analog Scale Score (Beads vs Placebo)
50; 47.5
SECONDARY
Pain Visual Analog Scale Score (Needles vs Placebo)
55; 47.5

Eligibility Criteria

bullets

Inclusion Criteria

  • Pregnant up to 13 weeks gestation
  • Seeking aspiration abortion for any first trimester induced abortion, abnormal pregnancy, early pregnancy loss, retained products of conception, or molar pregnancy
  • English- or Spanish-speaking
  • Willingness to be randomized into one of the three arms.

Exclusion Criteria

  • Allergy to adhesives or gold
  • Allergy or intolerance to ibuprofen or 1% lidocaine (paracervical block)
  • Congenital anomaly or infection of the ear.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03896022). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search